Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49

NCT04142242 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

471

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Infection (Healthy Volunteers)

Interventions

BIOLOGICAL: Meningococcal Polysaccharide (serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
OTHER: Blood sample

Sponsor

Sanofi Pasteur, a Sanofi Company